Two Blokes

SRPT Down After Third Death in Muscular Dystrophy Gene Therapy Program

  • click to rate
    Posted by Two Blokes Mon at 5:30 PM - Filed in Stock - 2 views
    Sarepta plummets after a third death in its muscular dystrophy program for investigational gene therapies, prompts FDA action and intensifies safety scrutiny.